— Know what they know.
Not Investment Advice

PRQR NASDAQ

ProQR Therapeutics N.V.
1W: -0.6% 1M: -23.7% 3M: -4.7% YTD: -17.6% 1Y: -24.1% 3Y: +18.8% 5Y: -79.0%
$1.64
+0.01 (+0.31%)
 
Weekly Expected Move ±6.4%
$1 $2 $2 $2 $2
NASDAQ · Healthcare · Biotechnology · Tech Score Strong Sell · Power 32 · $172.2M mcap · 64M float · 1.49% daily turnover · Short 60% of daily vol

📊 Key Metrics

TTM
$19M
Revenue
+12.7% YoY
$-42M
Net Income
-6.9% YoY
$-50M
Free Cash Flow
-16.4% YoY
91.9%
Gross Margin
-100.7%
Op. Margin
-99.6%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-57.9%
ROA-31.3%
ROIC139.7%

Valuation

P/E-3.7
P/B2.0
EV/EBITDA0.0

Leverage

Debt/Equity0.17
Current Ratio3.49
Interest Cov.0.0x

Quality Scores

Piotroski F2/9
Altman Z—
Beneish M-0.92

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms